We undertake pioneering and world-class research into heart and lung disease. Through our research, we develop new treatments, improve care for patients and help to inform decision-making and policy across the NHS and beyond.
In response to the pandemic most of our clinical research projects were suspended in March 2020. As we begin to resume some of these projects, we have produced guidance documents for researchers, hospital staff and external sponsors. These are to ensure the safe reactivation of research activity on site, while allowing and maintaining regulatory oversight.